Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Loading...

Submitting the form, please do not close the page and
ensure that your network is smooth to avoid the email being unable to be sent.

The Collagen & Hyaluronic Acid Company

Maxigen Biotech Inc., as a specialist in the medical device industry, offers innovative products from five disciplines and is certified by CE, FDA,  NMPA, and MDSAP product certifications. We are committed to using science to join and delight human life. Join our mission.

About MBI

Maxigen Biotech Inc. (MBI) was founded in December 1998. Next year, MBI stationed at National Yang-Ming University and set up an incubation center at there to conduct the R&D work of collagen. 

 

MBI utilizes its core competence in biopolymers and has developed a broad range of applications in areas such as medical devices and skincare products. MBI has been dedicated to the development and application medical device of collagen and hyaluronic acid.

 

Headquarters was moved to Hwa-Ya Technology park in July 2016. Our major shareholders include TCI Bio, GIH Group, and – NuVasive Inc., a Nasdaq-listed medical device company in the US.

History

2021
  • TCI Co.,Ltd became the largest shareholder,and Mr. Vincent Lin has been elected as the Chairman Formosa Biomedical Technology Crop. to invest via private placement.
  • Formosa Biomedical Technology Corp. to invest via private placement.
2022
  • The National Brand Yushan Award – MBI Won the Outstanding Enterprise Award.
1998

Established in 1998

2002

Established the medical device & cosmetic Dep.

2006

Certified by US FDA on medical consumables/device

2013

Listed in TWSE

2017

The medical consumables/device was certified in Indonesia.

2018

The medical consumables/device was certified in Russia, Malaysia, and Taiwan.

2019
  • The medical consumables/device was certified in Europe.
2021
  • TCI Co.,Ltd became the largest shareholder,and Mr. Vincent Lin has been elected as the Chairman Formosa Biomedical Technology Crop. to invest via private placement.
  • Formosa Biomedical Technology Corp. to invest via private placement.
2022
  • The National Brand Yushan Award – MBI Won the Outstanding Enterprise Award.
1998

Established in 1998

2002

Established the medical device & cosmetic Dep.

Global Footprint

mbi sales map

About TCI Group

We joined the TCI Group in 2021, which covers health food, medical devices, genetic testing, daily products, and pet health food. With the concept of “creating an integrated bioscience design trading company,” we are committed to expanding various upstream and downstream areas of life, health, and consumption to form a dense network.